首页> 外文期刊>Oncology Research >miR-202 Inhibits Cell Proliferation, Migration, and Invasion by Targeting Epidermal Growth Factor Receptor in Human Bladder Cancer
【24h】

miR-202 Inhibits Cell Proliferation, Migration, and Invasion by Targeting Epidermal Growth Factor Receptor in Human Bladder Cancer

机译:MiR-202通过靶向人膀胱癌中的表皮生长因子受体来抑制细胞增殖,迁移和侵袭

获取原文
获取原文并翻译 | 示例
           

摘要

Recent studies have demonstrated that miR-202 is associated with several types of cancer; however, the expression and function of miR-202 have not been investigated in bladder cancer. We analyzed the expression of miR-202 in bladder cancer tissues and adjacent noncancerous tissues. The effect of miR-202 on the proliferation, migration, and invasion was evaluated by in vitro assays. The target gene of miR-202 was assessed by luciferase reporter assay. In this study. miR-202 was found to be significantly downregulated in bladder cancer cell lines and tissues and was highly correlated with the T classification. N classification, grade, and recurrence. Ectopic expression of miR-202 suppressed cell viability, colony formation, cell migration. and invasion in vitro and inhibited xenograft tumor growth in vivo. Inversely, downregulation of miR-202 had contradictory effects. The 3'-untranslated region (3'-UTR) of epidermal growth factor receptor (EGFR) was identified as a direct target of miR-202 using luciferase reporter assays. and knockdown of EGFR enhanced miR-202-inhibited cell proliferation, migration. and invasion. In conclusion, miR-202 suppresses bladder cancer carcinogenesis and progression by targeting EGFR, thereby representing a potential target for miRNA-based therapy for bladder cancer in the future.
机译:最近的研究表明MIR-202与若干类型的癌症有关;然而,在膀胱癌中尚未研究miR-202的表达和功能。我们分析了膀胱癌组织和相邻的非癌组织中miR-202的表达。 MiR-202对体外测定评估了miR-202对增殖,迁移和侵袭的影响。通过荧光素酶报告酶测定评估miR-202的靶基因。在这项研究中。发现miR-202在膀胱癌细胞系和组织中显着下调,并且与T分类高度相关。 n分类,等级和复发。 miR-202抑制细胞活力,菌落形成,细胞迁移的异位表达。在体外侵袭并抑制体内异种移植肿瘤生长。相反,MIR-202的下调具有矛盾的效果。表皮生长因子受体(EGFR)的3'-未翻转的区域(3'-UTR)用荧光素酶报告分析鉴定为miR-202的直接靶标。和敲低预期增强miR-202抑制细胞增殖,迁移。和入侵。总之,MiR-202通过靶向EGFR抑制膀胱癌致癌和进展,从而代表未来膀胱癌的基于miRNA疗法的潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号